Emcure Pharmaceuticals: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 please find enclosed herewith Monitoring Agency Report for the quarter ended September 30 2024 issued by CARE Ratings Limited the Monitoring Agency appointed in respect of utilization of proceeds of the Initial Public Offer of the Company.